Otonomy Suspends Development of Lead Drug After Phase III Flop, Stock Plunges Post author:Sam Post published:August 29, 2017 Post category:BioPharma August 30, 2017By Alex Keown, BioSpace… Source: BioSpace You Might Also Like ReachBio LLC Celebrates 10 Years In Business September 11, 2017 GOP Congressman Lost $16.7 Million in Single Day on This Tanking Biotech Stock June 27, 2017 Bay Area Acerta Pharma Falsified Early Data on a Cancer Compound, Now in Clinical Trials October 5, 2017
Bay Area Acerta Pharma Falsified Early Data on a Cancer Compound, Now in Clinical Trials October 5, 2017
